HIV prevalence and testing practices among tuberculosis cases in London: A missed opportunity for HIV diagnosis?

Thorax

Volumn 65, Issue 1, 2010, Pages 63-69

  Rodger, A J ^a,b   Story, A ^c   Fox, Z ^a,d   Hayward, A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d Copenhagen HIV Programme ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BANGLADESH; CENTRAL NERVOUS SYSTEM DISEASE; CHINESE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENDER; GROUPS BY AGE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; INDIAN; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; PAKISTAN; PATIENT ATTITUDE; PRIORITY JOURNAL; SCREENING TEST; SRI LANKA; TREATMENT REFUSAL; UNITED KINGDOM;

EID: 73449121108     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.122754     Document Type: Article

References (31)

1. Nunn P, Reid A, De Cock KM. Tuberculosis and HIV infection: the global setting. J Infect Dis 2007;196(Suppl 1):S5-14.
2. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
3. Antonucci G, Girardi F, Raviglione MC, et al. Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study. JAMA 1995;274:143-8.
4. Lienhardt C, Rodrigues LC. Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1997;1:196-204.
5. Rose AM, Sinka K, Watson JM, et al. An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Thorax 2002;57:442-5.
6. Ahmed AB, Abubakar I, Delpech V, et al. The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003.Thorax 2007;62:672-6.
7. Story A, Murad S, Roberts W, et al. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 2007;62:667-71.
8. Haar CH, Cobelens FG, Kalisvaart NA, et al. HIV prevalence among TB patients in the Netherlands, 1993-2001: trends and risk factors. Int J Tuberc Lung Dis 2006;10:768-74.
9. Albalak R, O'Brien RJ, Kammerer JS, et al. Trends in TB/HIV virus co-morbidity, US 1993-2004. Arch Intern Med 2007;167:2443- 52.
10. Harris T, Panaro L, Phypers M, et al. HIV testing among Canadian tuberculosis cases from 1997 to 1998. Can J Infect Disease Med Microbial 2006;17:165-8.
11. Bowen EF, Rice PS, Cooke NT, et al. HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts. Lancet 2000;356:1488-99.
12. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55:1-17.
13. British HIV Association. UK National Guidelines for HIV testing. London: BHIVA, 2008. http://www.bhiva.org/documents/Guidelines/ Testing/GlinesHIVTest08.pdf.
14. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
15. Dart S, Alder D, Mamdani M, et al. HIV testing in TB clinics: a problem in practice? Thorax 2006;61:271-2.
16. Erwin J, Morgan M, Britten N, et al. Pathways to HIV testing and care by black African and white patients in London. Sex Transm Infect 2002;78:37-9.
17. Nnoaham KE, Pool R, Bothamley G, et al. Perceptions and experiences of tuberculosis among African patients attending a tuberculosis clinic in London. Int J Tuberc Lung Dis 2006;10:1013-7.
18. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50.
19. Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. JAIDS 2007;46(Suppl 1):S3-8.
20. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. JAIDS 2005;39:446-53.
21. Castilla J, Del Romero J, Hernando V, et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. JAIDS 2005;40:96-101.
22. British HIV Association (BHIVA). Clinical audit report 2005-6. HIV-related deaths in the HAART era. London: BHIVA, 2006. http://www.bhiva.org/documents/ClinicalAudit/AnnualReports/AuditRep2005-6.pdf
23. Liddicoat RV, Horton NJ, Urban R, et al. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 2004;19:349-56.
24. Centers for Disease Control and Prevention (CDC). Missed opportunities for earlier diagnosis of HIV infection - South Carolina, 1997-2005. MMWR 2006;55:1269-72.
25. Klein D, Hurley LB, Merrill D, et al. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. JAIDS 2003;32:143-52.
26. Hamill M, Burgoine K, Farrell F, et al. Time to move towards opt-out testing for HIV in the UK. BMJ 2007;334:1352-4.
27. Walker N, Kliner M, Turner D, et al. Hepatotoxicity and anti-tuberculosis therapy: time to revise UK guidelines? Thorax 2009;64:918.
28. Donaldson L, Beasley C. Improving the detection and diagnosis of HIV in non-HIV specialties including primary care. London: Department of Health, 2007.
29. Health Protection Agency. The UK collaborative group for HIV and STI surveillance. Testing Times. HIV and other sexually transmitted infections in the United Kingdom. London: Health Protection Agency Centre for Infections, 2007. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/ HPAweb-C/1203084355941.
30. Health Protection Agency and UK National Screening Committee. Infectious diseases in pregnancy screening programme: report on 2005-2007 data. London: Health Protection Agency, March 2009. Infectious Diseases in Pregnancy Screening Programme: 2007/8 Annual Report and 2005-2007 Surveillance Data.
31. Iskander R, Wass T, Jones J, et al. Communicable Disease Surveillance Centre Annual Report 2001. London: London Regional Office, 2001.